Clinical Trial Update: Study of ORIC-944 in Patients With Metastatic Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ORIC-944 in patients with metastatic prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ORIC-944

Snippet

Sponsor: ORIC Pharmaceuticals | Conditions: Metastatic Prostate Cancer | Phase 1 | Status: RECRUITING